Tue. Oct 4th, 2022
Alembic Pharma arm inks pact with Curon to develop cancer treatment drug in Greater China According to a regulatory filing, Rhizen Pharmaceuticals is a Switzerland-based privately held clinical-stage biopharmaceutical company, and Curon Biopharmaceutical is a clinical-stage innovative biopharmaceutical company with facility in Shanghai.